Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheridan

Showing results (121-130 of 7,540) with videos related to

Pageof 754
Sort By:
Nature Biotechnology|September 2, 2004
EU to review rare disease drugs market exclusivityCormac Sheridan
Nature Biotechnology|October 8, 2004
A taste of the futureCormac Sheridan
JAMA|October 19, 1984
From the NIH. Tetracyclines block collagenase activityP Sheridan
Critical Care Medicine|March 21, 2002
Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned childrenRob Sheridan
Nature Biotechnology|March 11, 2021
Bispecific antibodies poised to deliver wave of cancer therapiesCormac Sheridan
Nature Biotechnology|April 4, 2019
Llama-inspired antibody fragment approved for rare blood disorderCormac Sheridan
Journal of Cataract and Refractive Surgery|September 25, 2012
Effect of corrected distance visual acuity on intraocular lens power prediction accuracySheridan Lam
Nature Biotechnology|October 12, 2012
SGLT2 inhibitors race to enter type-2 diabetes marketCormac Sheridan
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|July 7, 2012
Endothelial keratoplasty with pars plana air-fluid exchange in the absence of an intact lens-iris diaphragmSheridan Lam
Mutation Research|October 1, 1971
The effects of the time interval in fractionated x-ray treatment of mouse spermatogoniaW Sheridan
Pageof 754

Showing results (121-130 of 7,540) with videos related to

Sort By:
Pageof 754
Nature Biotechnology|September 2, 2004
EU to review rare disease drugs market exclusivityCormac Sheridan
Nature Biotechnology|October 8, 2004
A taste of the futureCormac Sheridan
JAMA|October 19, 1984
From the NIH. Tetracyclines block collagenase activityP Sheridan
Critical Care Medicine|March 21, 2002
Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned childrenRob Sheridan
Nature Biotechnology|March 11, 2021
Bispecific antibodies poised to deliver wave of cancer therapiesCormac Sheridan
Nature Biotechnology|April 4, 2019
Llama-inspired antibody fragment approved for rare blood disorderCormac Sheridan
Journal of Cataract and Refractive Surgery|September 25, 2012
Effect of corrected distance visual acuity on intraocular lens power prediction accuracySheridan Lam
Nature Biotechnology|October 12, 2012
SGLT2 inhibitors race to enter type-2 diabetes marketCormac Sheridan
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|July 7, 2012
Endothelial keratoplasty with pars plana air-fluid exchange in the absence of an intact lens-iris diaphragmSheridan Lam
Mutation Research|October 1, 1971
The effects of the time interval in fractionated x-ray treatment of mouse spermatogoniaW Sheridan
Pageof 754